PUBLIC CONTRACT · 2022
Aquisição de Medicamentos do Grupo 4: Sangue, ao abrigo de CPA's da SPMS (CAPS)
- Contract value
- €62.16
- Signed on
- 4 March 2022
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9167369PUBLISHED DESCRIPTION
IG000060.52022
Parties involved
- Place of performance
- Portugal, Évora
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- LAB. FARMACEUTICOS ROVI, SA. · Tax ID 980166705
- Bidder
- SANDOZ FARMACEUTICA, LDA · Tax ID 506985261
- Bidder
- GENERIS-FARMACEUTICA, S.A. · Tax ID 508107997
- Bidder
- MYLAN, LDo · Tax ID 502248793
- Bidder
- OVERPHARMA - PROD. MÉDICOS E FARMACÊUTICOS, LDA. · Tax ID 505792362
- Bidder
- Sanofi - Produtos Farmacêuticos, Lda. · Tax ID 500134960
Values and timeline
- Contract price
- €62.16
- Procedure base price
- €122.92
- Total effective price
- €104.65
- Publication date
- 5 April 2022
- Award date
- 24 February 2022
- Signing date
- 4 March 2022
- Performance period
- 335 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2020/18 - Medicamentos do grupo 4: sangue
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5750705
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.